These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 34366826)

  • 21. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunotherapy for the treatment of Alzheimer's disease: amyloid-β or tau, which is the right target?
    Castillo-Carranza DL; Guerrero-Muñoz MJ; Kayed R
    Immunotargets Ther; 2014; 3():19-28. PubMed ID: 27471697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Research Progress on the Etiology and Pathogenesis of Alzheimer's Disease from the Perspective of Chronic Stress.
    Liu YS; Zhao HF; Li Q; Cui HW; Huang GD
    Aging Dis; 2023 Aug; 14(4):1292-1310. PubMed ID: 37163426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Herpesviral infections and antimicrobial protection for Alzheimer's disease: Implications for prevention and treatment.
    Qin Q; Li Y
    J Med Virol; 2019 Aug; 91(8):1368-1377. PubMed ID: 30997676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circadian and sleep dysfunction in Alzheimer's disease.
    Uddin MS; Tewari D; Mamun AA; Kabir MT; Niaz K; Wahed MII; Barreto GE; Ashraf GM
    Ageing Res Rev; 2020 Jul; 60():101046. PubMed ID: 32171783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. APOE and Alzheimer's Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer's Pathogenesis.
    Uddin MS; Kabir MT; Al Mamun A; Abdel-Daim MM; Barreto GE; Ashraf GM
    Mol Neurobiol; 2019 Apr; 56(4):2450-2465. PubMed ID: 30032423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting neuroinflammation in Alzheimer's disease.
    Bronzuoli MR; Iacomino A; Steardo L; Scuderi C
    J Inflamm Res; 2016; 9():199-208. PubMed ID: 27843334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Connecting the Dots: Linking the Biochemical to Morphological Transitions in Alzheimer's Disease.
    Baig AM
    ACS Chem Neurosci; 2019 Jan; 10(1):21-24. PubMed ID: 30160095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alzheimer's Disease, Inflammation, and the Role of Antioxidants.
    Sinyor B; Mineo J; Ochner C
    J Alzheimers Dis Rep; 2020 Jun; 4(1):175-183. PubMed ID: 32715278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease.
    Suh YH; Checler F
    Pharmacol Rev; 2002 Sep; 54(3):469-525. PubMed ID: 12223532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The antimicrobial protection hypothesis of Alzheimer's disease.
    Moir RD; Lathe R; Tanzi RE
    Alzheimers Dement; 2018 Dec; 14(12):1602-1614. PubMed ID: 30314800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of optogenetic Amyloid-β distinguishes between metabolic and physical damages in neurodegeneration.
    Lim CH; Kaur P; Teo E; Lam VYM; Zhu F; Kibat C; Gruber J; Mathuru AS; Tolwinski NS
    Elife; 2020 Mar; 9():. PubMed ID: 32228858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liraglutide Protects Against Brain Amyloid-β
    Duarte AI; Candeias E; Alves IN; Mena D; Silva DF; Machado NJ; Campos EJ; Santos MS; Oliveira CR; Moreira PI
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32143329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Early Events That Initiate β-Amyloid Aggregation in Alzheimer's Disease.
    Zhang X; Fu Z; Meng L; He M; Zhang Z
    Front Aging Neurosci; 2018; 10():359. PubMed ID: 30542277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Learning from the Past: A Review of Clinical Trials Targeting Amyloid, Tau and Neuroinflammation in Alzheimer's Disease.
    Ceyzériat K; Zilli T; Millet P; Frisoni GB; Garibotto V; Tournier BB
    Curr Alzheimer Res; 2020; 17(2):112-125. PubMed ID: 32129164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Periodontal Disease and Periodontal Disease-Related Bacteria Involved in the Pathogenesis of Alzheimer's Disease.
    Matsushita K; Yamada-Furukawa M; Kurosawa M; Shikama Y
    J Inflamm Res; 2020; 13():275-283. PubMed ID: 32636667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amelioration of Alzheimer's disease pathology and cognitive deficits by immunomodulatory agents in animal models of Alzheimer's disease.
    Martinez B; Peplow PV
    Neural Regen Res; 2019 Jul; 14(7):1158-1176. PubMed ID: 30804241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perspective Insights into Disease Progression, Diagnostics, and Therapeutic Approaches in Alzheimer's Disease: A Judicious Update.
    Jan AT; Azam M; Rahman S; Almigeiti AMS; Choi DH; Lee EJ; Haq QMR; Choi I
    Front Aging Neurosci; 2017; 9():356. PubMed ID: 29163138
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.